July 15, 2020

Short-Term Corticosteroid Prescriptions Also Present Some Serious Risks

Pharmacists might consider it routine to fill prescriptions for short-term corticosteroids designed for use of less than 2 weeks. A new study cautions, however, that steroids present some risks, even when they are not used in the long term. Find out about the dangers uncovered in a very large case series from Taiwan. 


ACE Inhibitors, ARB Medications Might Protect Against
Colorectal Cancer

Common drugs used to treat cardiovascular conditions might also be protective against colorectal cancer. Angiotensin converting enzyme (ACE) inhibitor or angiotensin II receptor blocker (ARB) medications reduced the risk of developing the cancer in some situations, according to a new study. Here are more details. 

Endocrine Disorder Patients With COVID-19 Likely to Need Drug Adjustments

Medication management can be challenging when patients with pre-existing endocrine disorders develop COVID-19, a new review suggests. Find out what types of dosage changes might be required and which complications can worsen outcomes.  


Dose Tapering Didn’t Affect QoL for Psoriasis Patients on Biologics

While not determined to be noninferior, reducing dosage of biologics in psoriasis patients appears feasible. That’s according to a new study of patients on adalimumab, etanercept, or ustekinumab. Researchers identified no reduction in quality of life in those receiving lower doses. Here is more information. 

Facebook   Twitter   USP Google App   USP itunes App
U.S. Pharmacist
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -